✦ LIBER ✦

Budesonide is superior to mesalazine in maintaining disease remission for patients with steroiddependent Crohn's disease

✍ Scribed by Mantzaris, Gerassimos J.; Petraki, Kalliopi; Archavlis, Emmanuel; Chadio-Iordanidou, Helen; Christidou, Angela; Zografos, Christos; Chiotakakou, Efterpi; Triantafyllou, George

Book ID: 121902331
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 178 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)85262-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Budesonide is superior to mesalazine in

Budesonide is superior to mesalazine in maintaining disease remission for patients with steroid-dependent Crohn's disease

✍ G.J. Mantzaris; K. Petraki; E. Chadio; E. Archavlis; A. Christidou; G. Triantafy 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Budesonide superior to mesalazine in act

Budesonide superior to mesalazine in active Crohn’s disease

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 221 KB

Azathioprine is superior to budesonide i

Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease

✍ Gerassimos J. Mantzaris; Angeliki Christidou; Michael Sfakianakis; Anastassios R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Background: The effects of azathioprine (AZA) and budesonide (BUD) on mucosal healing and histologic remission of Crohn's disease (CD) are insufficiently studied. In this prospective study we evaluated the comparative effects of AZA and BUD on endoscopic and histologic activity in patients with

Budesonide versus mesalamine for maintai

Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease

✍ Mantzaris, Gerassimos J.; Petraki, Kalliopi; Sfakianakis, Michael; Archavlis, Em 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Is immunomodulator monotherapy enough to

Is immunomodulator monotherapy enough to maintain remission in Crohn’s disease?

✍ Denise P. Guarino; Gerard E. Mullin 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 37 KB

Safety and effectiveness of long-term bu

Safety and effectiveness of long-term budesonide treatment in maintaining remission in patients with mild-to-moderate Crohn's disease

✍ Antonio Tursi; Gian Marco Giorgetti; Giovanni Brandimarte; Walter Elisei 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views